Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (411-420 of 927) with videos related to

Pageof 93
Sort By:
Thrombosis and Haemostasis|October 2, 2015
Platelet density per monocyte predicts adverse events in patients after percutaneous coronary interventionBert Rutten, Mark Roest, Elizabeth A McClellan, et al.
Pharmacoepidemiology and Drug Safety|March 28, 2026
Methodological Challenges of Emulating a Target Trial to Assess Effectiveness of Timing of PCSK9 Inhibitor Treatment Initiation Post Myocardial InfarctionThomas Cars, Stefan Gustafsson, Queenie Chan, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 3, 2009
Assessment of global left ventricular function and volumes with 320-row multidetector computed tomography: A comparison with 2D-echocardiographyFleur R de Graaf, Joanne D Schuijf, Joëlla E van Velzen, et al.
Disease Markers|July 8, 2011
Asymmetric dimethylarginine (ADMA) levels display a morning peak in patients with acute myocardial infarctionSandrin C Bergheanu, Arnoud van der Laarse, Johanna G van der Bom, et al.
Neurology|November 1, 2013
Total cerebral blood flow and mortality in old age: a 12-year follow-up studyBehnam Sabayan, Jeroen van der Grond, Rudi G Westendorp, et al.
The American Journal of Cardiology|March 10, 2010
Evaluation of contraindications and efficacy of oral Beta blockade before computed tomographic coronary angiographyFleur R de Graaf, Joanne D Schuijf, Joëlla E van Velzen, et al.
Atherosclerosis|November 1, 2005
C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003S Matthijs Boekholdt, C Erik Hack, Manjinder S Sandhu, et al.
Cancers|December 23, 2023
Relation between Coronary Artery Calcium Score and Cardiovascular Events in Hodgkin Lymphoma Survivors: A Cross-Sectional Matched Cohort StudyElissa A S Polomski, Julius C Heemelaar, Michiel A de Graaf, et al.
American Heart Journal|August 10, 2016
Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes TrialsPaul M Ridker, Pierre Amarenco, Robert Brunell, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 30, 2010
Improved aortic pulse wave velocity assessment from multislice two-directional in-plane velocity-encoded magnetic resonance imagingJos J M Westenberg, Albert de Roos, Heynric B Grotenhuis, et al.
Pageof 93

Showing results (411-420 of 927) with videos related to

Sort By:
Pageof 93
Thrombosis and Haemostasis|October 2, 2015
Platelet density per monocyte predicts adverse events in patients after percutaneous coronary interventionBert Rutten, Mark Roest, Elizabeth A McClellan, et al.
Pharmacoepidemiology and Drug Safety|March 28, 2026
Methodological Challenges of Emulating a Target Trial to Assess Effectiveness of Timing of PCSK9 Inhibitor Treatment Initiation Post Myocardial InfarctionThomas Cars, Stefan Gustafsson, Queenie Chan, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 3, 2009
Assessment of global left ventricular function and volumes with 320-row multidetector computed tomography: A comparison with 2D-echocardiographyFleur R de Graaf, Joanne D Schuijf, Joëlla E van Velzen, et al.
Disease Markers|July 8, 2011
Asymmetric dimethylarginine (ADMA) levels display a morning peak in patients with acute myocardial infarctionSandrin C Bergheanu, Arnoud van der Laarse, Johanna G van der Bom, et al.
Neurology|November 1, 2013
Total cerebral blood flow and mortality in old age: a 12-year follow-up studyBehnam Sabayan, Jeroen van der Grond, Rudi G Westendorp, et al.
The American Journal of Cardiology|March 10, 2010
Evaluation of contraindications and efficacy of oral Beta blockade before computed tomographic coronary angiographyFleur R de Graaf, Joanne D Schuijf, Joëlla E van Velzen, et al.
Atherosclerosis|November 1, 2005
C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003S Matthijs Boekholdt, C Erik Hack, Manjinder S Sandhu, et al.
Cancers|December 23, 2023
Relation between Coronary Artery Calcium Score and Cardiovascular Events in Hodgkin Lymphoma Survivors: A Cross-Sectional Matched Cohort StudyElissa A S Polomski, Julius C Heemelaar, Michiel A de Graaf, et al.
American Heart Journal|August 10, 2016
Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes TrialsPaul M Ridker, Pierre Amarenco, Robert Brunell, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 30, 2010
Improved aortic pulse wave velocity assessment from multislice two-directional in-plane velocity-encoded magnetic resonance imagingJos J M Westenberg, Albert de Roos, Heynric B Grotenhuis, et al.
Pageof 93